Germany - Drugs

Description

See description of procurement
This is not an open procedure, but a so-called open-house model! The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded in the open-house model are not subject to public procurement law due to the lack of a selection decision. The AOK Bavaria intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active ingredient octreotide, ATC H01CB02, in accordance with Section 130a (8) of the German Social Code, Book V (SGB V). The AOK Bavaria offers to conclude identical and non-individually negotiable rebate agreements to all interested pharmaceutical companies that meet the eligibility requirements listed below. The earliest possible start date of the contract is 01.11.2023, all contracts end on 31.10.2025. A conclusion of the contract is possible at any time during this period, but no later than 05.09.2025. The contracts can be terminated with a notice period of one month to the end of the month. In the event of the entry into force of a rebate contract concluded by nationwide or state-specific open procedure for drugs with the active ingredient that is the subject of the contract, the open-house agreements shall automatically cease to apply for the corresponding term. A contract will be concluded with all interested pharmaceutical companies that prove their suitability by means of a completed and signed self-declaration of reliability.The pharmaceutical entrepreneur must submit the completed and signed contract (the representative authority of the signatory(ies) must be evident from the excerpt from the commercial register, otherwise a power of attorney must be submitted) together with the completed and signed attachment "Determination of the medicinal products covered by the contract" and the completed and signed self-declaration of reliability.The documents can be submitted either in WRITTEN form, signed by hand, or ELECTRONIC form with a qualified electronic signature. 2 original copies of the documents signed by hand in WRITTEN form must be sent to the following address: AOK Bayern - Die GesundheitskasseVergabestelle SGB VZE25open-house RabattverträgeCarl-Wery-Str. 2881739 MunichELECTRONIC documents with a qualified electronic signature must be submitted via the communication area in the award portal www.dtvp.de.If complete and correct documents are received by the 05th of each month, the contract will start on the following first of the next month, otherwise on the following first of the month after next. In the case of documents signed by hand in WRITTEN FORM, sending the complete, completed and signed documents in advance by fax (089/62730650151), as a scan to the e-mail address vergabestelle1@by.aok.de or via the communication area in the award portal www.dtvp.de will meet the deadline if the complete and correct original documents in paper form are received by AOK Bavaria, AOK Bavaria, by the 10th day of the month. Please note the instructions for filling in the application form, which are available at www.dtvp.de under the award documents.Interested pharmaceutical companies can apply for activation of the award documents in the project room for the open house procedure on the portal www.dtvp.de. A link to the portal is provided in this document. A link to the portal is included in this announcement.Only pharmaceutical companies can be considered as potential contract partners. The documents of the open house procedure will only be made available to pharmaceutical companies as potential contract partners and are to be treated as strictly confidential. The confidential treatment of the documents is confirmed by the companies' application for activation.

Opportunity closing date

05 September 2025

Value of contract

£0-100k